Staar Surgical Q3 2024 Adj EPS $0.33 Beats $0.17 Estimate, Sales $88.60M Beat $86.91M Estimate
Portfolio Pulse from Benzinga Newsdesk
Staar Surgical reported Q3 2024 earnings of $0.33 per share, significantly beating the analyst estimate of $0.17. Sales were $88.60 million, surpassing the $86.91 million estimate and marking a 10.33% increase from the previous year.
October 30, 2024 | 8:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Staar Surgical's Q3 2024 earnings per share of $0.33 exceeded expectations by 94.12%, and sales of $88.60 million also surpassed estimates. This strong performance indicates positive momentum for the company.
The significant beat on both EPS and sales suggests strong operational performance and potential investor confidence, likely leading to a positive short-term impact on STAA's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100